APA (7th ed.) Citation

BE, F., SW, W., CLL, S., GH, L., BP, L., CW, T., . . . YW, C. (2022). Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long-term outcomes in COVID-19 patients. American journal of hematology, 97(7), 915. https://doi.org/10.1002/ajh.26575

Chicago Style (17th ed.) Citation

BE, Fan, et al. "Hypercoagulability, Endotheliopathy, and Inflammation Approximating 1 year After Recovery: Assessing the Long-term Outcomes in COVID-19 Patients." American Journal of Hematology 97, no. 7 (2022): 915. https://doi.org/10.1002/ajh.26575.

MLA (9th ed.) Citation

BE, Fan, et al. "Hypercoagulability, Endotheliopathy, and Inflammation Approximating 1 year After Recovery: Assessing the Long-term Outcomes in COVID-19 Patients." American Journal of Hematology, vol. 97, no. 7, 2022, p. 915, https://doi.org/10.1002/ajh.26575.